Work

A systematic review of treatments for severe psoriasis.

Year: 2000
Type: review
Abstract: ObjectivesThis systematic review of the evidence base was carried out to compare the effectiveness of currently available treatments for severe psoriasis and to identify areas in need of further research. Methods Data sourcesSystematic searches of MEDLINE, EMBASE, the Cochrane Controlled Trials Register and the European Dermato-Epidemiology Network were undertaken.Report authors and drug manufacturers were also asked for information.The initial searches identified 2873 citations about psoriasis treatment. Study selection and assessment of validityStudies were considered eligible if they were randomised controlled trials (RCTs) of interventions for the treatment of moderate-to-severe chronic plaque psoriasis.Reports concerned exclusively with palmoplantar pustular psoriasis, guttate psoriasis or psoriatic arthritis were excluded.Relevant studies in any language were accepted.Studies were excluded if they contained data that had already been published elsewhere or if insufficient data were reported for analysis.Decisions about inclusion were made by two reviewers. Data extractionData concerning all outcomes of interest were extracted from all eligible studies and entered into spreadsheets.'guttate' lesions of 2-3 mm in diameter to plaques covering the whole lumbosacral area (i.e.> 20 cm in diameter).Irrespective of size, individual plaques are macroscopically identical.The most common sites of involvement are the extensor aspects of elbows and knees, the scalp, and lumbosacral region; however, any skin surface may be affected.Morphology varies according to site.In flexural sites, perineum, sub-mammary and axillae, the occlusive environment reduces induration and scaling but accentuates erythema.Scalp psoriasis rarely strays beyond the hairline and may occur in a seborrhoeic distribution in nasolabial folds, eyebrows and post-auricularly (so-called 'sebopsoriasis').The chronic plaque variety accounts for 85-90% of the cases of psoriasis, and this systematic reviewChapter 1* PASI = 0.1(E h + I h +D h )A h + 0.3(E t + I t + D t )A t + 0.2(E u + I u + D u )A u + 0.4(E l + I l + D l )A l .Erythema (E), induration (I) and desquamation (D) are assessed according to a 4-point scale: 0, no psoriasis; 1, slight; 2, moderate; 3, marked; and 4, very marked.The various sites are: h, head; t, trunk; u, upper limbs; and l, lower limbs.In terms of the skin area (A) of plaques, a numerical value is given based on the extent of the lesions at the specified sites: 1, < 10%; 2, 10-29%; 3, 30-49%; 4, 50-69%; 5, 70-89%; and 6, 90-100%.
Language: English
Subfield: Immunology
Open Access status: bronze
OpenAlex ID: W2013748954
FWCI: 0.586
Cites: 259
Cited by: 261
Related to: 10